Charles T. C. Chang
University of Kansas
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charles T. C. Chang.
Biochemical Pharmacology | 1981
Erik De Clercq; Jan Balzarini; J. Descamps; Christopher F. Bigge; Charles T. C. Chang; Panos Kalaritis; Mathias P. Mertes
Abstract 2′-Deoxyuridine derivatives containing styryl, 3-nitrostyryl, 4-nitrostyryl, and phenylethyl groups substituted at the 5-position of the pyrimidine ring have been evaluated for their effects on vaccinia and herpes simplex virus replication (in primary rabbit kidney cell cultures) and mouse leukemia L-1210 cell culture growth. 5-Phenylethyl-2′-deoxyuridine inhibited herpes simplex (type 1 and 2) virus-induced cytopathogenicity by 50 per cent at a dose ( id 50 ) of 10–30 μg/ml. It was inactive against tumor cell growth. The corresponding styryl derivative showed an id 50 of 30–70 μg/ml for herpes simplex virus, 20 μg/ml for vaccinia virus, and 280 μg/ml for L-1210 cell growth. 5(E)-(3-Azidostyryl)-2′-deoxyuridine 5′-phosphate inhibited vaccinia replication with an IC 50 of 20 μg/ml and L-1210 cell culture growth with an id 50 of 80 μg/ml. The nucleotides of these compounds were all potent reversible inhibitors of thymidylate synthetase ( Lactobacillus casei ) with the following K i K m ratios: 3-nitrostyryl, 0.035; 4-nitrostyryl, 0.05; 3-azidostyryl, 0.06; styryl, 0.08; and phenylethyl, 0.31. The photodecomposition of the azidostyryl derivative, a photoaffinity labeling reagent for thymidylate synthetase, was examined at two wavelengths.
Biochemical and Biophysical Research Communications | 1978
Mathias P. Mertes; Charles T. C. Chang; Erik De Clercq; Guang-Fu Huang; Paul F. Torrence
Abstract 5-Nitro-2′-deoxyuridine 5′-monophosphate was found to be an active sitedirected irreversible inhibitor of thymidylate synthetase from Lactobacillus caesi . Its K I was determined as 2.9 × 10 −8 M from a double-reciprocal plot of velocity vs substrate concentration.
Biochemical and Biophysical Research Communications | 1979
Christie B. Brouillette; Charles T. C. Chang; Mathias P. Mertes
5(α-Bromoacetyl)-2′-deoxyuridine 5′-phosphate is an active site-directed irreversible inhibitor of thymidylate synthetase from Lactobacillus casei. The reversible inhibition (KI4uM) is competitive with substrate and on incubation the reversible enzyme-inhibitor complex is converted to the irreversible complex with a first order rate constant (k2) of 0.15 min−1.
Biochemical and Biophysical Research Communications | 1980
E. De Clercq; Jan Balzarini; Charles T. C. Chang; Christopher F. Bigge; Panos Kalaritis; Mathias P. Mertes
Abstract The title compound is a photoaffinity labeling reagent for thymidylate synthetase, a key enzyme for the de novo biosynthesis of DNA. This compound is also a light-dependent inhibitor of murine (L-1210) and human (Namalva, Raji) tumor cell growth, and vaccinia virus replication.
Journal of Medicinal Chemistry | 1980
Joon Sup Park; Charles T. C. Chang; C.L. Schmidt; Yechiel Golander; Erik De Clercq; J. Descamps; Mathias P. Mertes
Journal of Medicinal Chemistry | 1979
Christie B. Brouillette; Charles T. C. Chang; Mathias P. Mertes
Journal of the American Chemical Society | 1981
Linda L. Maggiora; Charles T. C. Chang; Paul F. Torrence; Mathias P. Mertes
Journal of Medicinal Chemistry | 1980
C.L. Schmidt; Charles T. C. Chang; Erik De Clercq; J. Descamps; Mathias P. Mertes
Journal of Medicinal Chemistry | 1979
Joon Sup Park; Charles T. C. Chang; Mathias P. Mertes
Journal of Medicinal Chemistry | 1983
Linda L. Maggiora; Charles T. C. Chang; Mohamed E. Hasson; Christopher Franklin Bigge; Mathias P. Mertes